Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the Watanabe Heritable Hyperlipidemic Rabbit

Atherosclerosis

Volumn 132, Issue 1, 1997, Pages 119-122

  Nordestgaard, B G ^a   Agerholm Larsen, B ^a   Mortensen, A ^a   Hansen, B F ^a   Hansen, J F ^a   Ibsen, P ^a   Kjeldsen, K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Familial hypercholesterolemia; Low density lipoprotein; Postprandial lipoproteins

Indexed keywords

INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RECEPTOR BINDING; HYPERLIPIDEMIA; LETTER; LIPOPROTEIN METABOLISM; NONHUMAN; POSTPRANDIAL STATE; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0030748431     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00051-8     Document Type: Article

References (36)

1. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473–485.
2. Slyper AH. A fresh look at the atherogenic remnant hypothesis. Lancet 1992;340:289–291.
3. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153–158.
4. Goldstein JL, Hobbs HH, Brown MS. Familial Hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1985:1981–2030.
5. Hansen BF, Mortensen A, Hansen JF, Ibsen P, Frandsen H, Nordestgaard BG. Atherosclerosis in Watanabe Heritable Hyperlipidaemic rabbits. Evaluation of macroscopic, microscopic and biochemical methods and comparison of atherosclerosis variables. APMIS 1994;102:177–190.
6. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497– 507.
7. Yamada N, Shames DM, Havel RJ. Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits. J Clin Invest 1987;80:507–515.
8. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initation in Watanabe Heritable Hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987;7:9–23.
9. Beaumont JL, Assadollahi F. Retinyl palmitate labeled intestinally derived lipoproteins accumulate in the circulation of WHHL rabbits. Atherosclerosis 1990;85:103–111.
10. Bowler A, Redgrave TG, Mamo JCL. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe Heritable Hyperlipidaemic rabbits is defective. Biochem J 1991;276:381–386.
11. Shiomi M, Ito T, Shiraishi M, Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: Risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 1992;96:43–52.
12. Tashiro J, Nishide T, Shinomiya M, Shirai K, Saito Y, Yoshida S, Yamashita M, Ohskima H, Murayama H. The `midband' lipoprotein is a coronary risk factor in Japanese patients with familial hypercholesterolaemia. Scand J Clin Lab Invest 1993;53:335–338.
13. Nordestgaard BG, Lewis B. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis 1991;87:39–46.
14. Daley SJ, Herderick EE, Cornhill JF, Rogers KA. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 1: Differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler Thromb 1994;14:95–104.
15. Tatami R, Mabuchi H, Ueda K, Ueda R, Toshihiro H, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayana A, Kanaya H, Oiwake H, Genda A, Takeda R. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981;64:1174–1184.
16. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985;71:881–888.
17. Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987;75:124–130.
18. Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Detre KM, Levy RI. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987; II:62– 66.
19. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762–2770.
20. Mahley RW, Rall SC. Type III hyperlipoproteinemia (Dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds), The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995:1953–1980.
21. Nestel PJ, Fidge NH, Tan MH. Increased lipoprotein-remnant formation in chronic renal failure. New Engl J Med 1982;307:329–333.
22. Kasama T, Yoshino G, Iwatani I, et al. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics. Atherosclerosis 1987;63:263–266.
23. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J, Roy P. Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study. Atherosclerosis 1987;65:181–189.
24. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;85:193–202.
25. Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653–662.
26. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992;23:823–828.
27. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336–1345.
28. Uiterwaal CSPM, Grobbee DE, Witteman JCM, van Stiphout WAHJ, Krauss XH, Havekes LM, de Bruijn AM, van Tol A, Hofman A. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994;121:576–583.
29. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83–97.
30. Shaikh M, Wootton R, Nordestgaard BG, Baskerville P, Lumley JS, La Ville AE, Quiney J, Lewis B. Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60–400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb 1991;11:569–577.
31. Nordestgaard BG, Wootton R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol 1995;15:534–542.
32. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994;14:1767–1774.
33. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis: Pathophysiological considerations. J Intern Med 1994;236, suppl 736:33–39.
34. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840–856.
35. Barter PJ, Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis 1996;121:1–12.
36. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2–14.